PPARA and corneal disorder: Currently, the studies discussed in this article largely employ the utilisation of animal models, showcasing great promise and broadening our knowledge base on the underlying mechanisms of PPAR agents in treating corneal diseases while serving as a platform to test these novel PPAR therapeutic modalities.